The blood-testing firm Theranos has pushed back fiercely on The Wall Street Journal's reporting on a host of irregularities it found with the company's cheaper, less-intrusive blood-tests. In one statement, Theranos called a particular story "inaccurate, misleading and defamatory."
So we thought this long interview with the Journal reporter who's written those stories was interesting. John Carreyrou appeared last week on the video podcast "This Week in Startups," hosted by investor and entrepreneur Jason Calicanis. In the interview, Carreyrou defends his reporting and recaps some of his findings. He also says he repeatedly tried to interview Theranos founder Elizabeth Holmes but was rebuffed. You can see selected clips from the interview here, including one in which he talks about the Journal's vetting process.
Keep in mind Calicanis himself is a big critic of Theranos. He is not the most objective interviewer. (And you'll also have to sit through some ads.) Also keep in mind, again, that Theranos denies the claims made in the reports, which include allegations that the company hid test results and data that cast doubt on the accuracy of its technology.